MENU
EYEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eyenovia (EYEN) Ownership - Who owns Eyenovia?
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
295 Madison Avenue
Phone
+1 833 393-6684
Employees
57
Web
https://www.eyenovia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.04M
P/E Ratio
N/A
Total Cash
26.72M
Projected Growth
N/A
Total Debt
13.01M
Revenue
31.83K
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
9.27
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
EYEN
Capitalization
9.04M
P/E Ratio
N/A
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
26.7M
Total Cash/Share
9.27
Total Debt
13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
31.8K
ROE
N/A
Book Value
3.72M
P/B Ratio
0.57
Cash Flow
N/A
Earnings
-55.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.64K
Current Ratio
0.74
Current Revenue Per Employee
28.51
Dividends Per Share - Security
N/A
EBITDA
-34.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
-8055.20
Revenue To Assets
-131.22
Shares Held By Institutions
782K
Shares Outstanding - Current
2.88M
Total Liabilities
19.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-73.159
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which delivers sight saving therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
295 Madison Avenue
Phone
+1 833 393-6684
Employees
57
Web
https://www.eyenovia.com